{"id":3790,"count":5,"description":"Hypotyreose \u2014 en underaktiv skjoldbruskkirtel \u2014 rammer cirka <strong>5 % af voksne verdens over<\/strong>, hvor kvinder diagnosticeres fem til ti gange hyppigere end m\u00e6nd. Skjoldbruskkirtlen sidder foran p\u00e5 halsen og producerer to hormoner: <strong>thyroxin (T4)<\/strong> og <strong>triiodthyronin (T3)<\/strong>, som sammen styrer stofskiftet i hver enkelt kropscelle. N\u00e5r kirtlen svigter \u2014 oftest p\u00e5 grund af autoimmun destruktion (Hashimotos thyreoiditis), kirurgi for knuder eller kr\u00e6ft, radiojodbehandling, medf\u00f8dt frav\u00e6r eller alvorlig jodmangel \u2014 opst\u00e5r symptomerne gradvist: tr\u00e6thed, v\u00e6gt\u00f8gning, kuldeintoleranse, forstoppelse, t\u00f8r hud, h\u00e5rtab, depression og hjerne-t\u00e5ge. Ubehandlet hypotyreose under graviditet \u00f8ger risikoen for spontan abort og h\u00e6mmer fosterets neuroudvikling. Diagnosen er biokemisk: forh\u00f8jet <strong>thyreoideastimulerende hormon (TSH)<\/strong> med lavt eller lavt-normalt <strong>frit T4<\/strong>.\n\nTreatment is hormone replacement. The first-line drug is <strong>levothyroxin<\/strong> &mdash; synthetic T4 &mdash; taken once daily on an empty stomach. Levothyroxine has a long half-life (~7 days) which produces smooth blood levels with simple once-daily dosing. The body converts T4 to the more active T3 in peripheral tissues exactly as it does with the natural hormone, which is why most patients feel completely well on T4 alone. Dose is titrated against TSH every 6&ndash;8 weeks until the level sits in the target range (usually 0.5&ndash;2.5 mIU\/L), then monitored annually.\n\nLevothyroxine (T4) brands stocked at MedsBase\nAll four brands below contain the identical active ingredient &mdash; <strong>levothyroxin natrium<\/strong>. De adskiller sig i producent, hj\u00e6lpestoffer og prisniveau. N\u00e5r din TSH er stabil p\u00e5 \u00e9t m\u00e6rke, undg\u00e5r du ved at holde dig til det de sm\u00e5 bio\u00e6kvivalensvariationer, der kan flytte TSH uden for m\u00e5lomr\u00e5det.\n\n<a href=\"https:\/\/medsbase.com\/da\/eltroxin\/\"><strong>Eltroxin<\/strong><\/a> \u2014 GlaxoSmithKline (GSK), 100 mcg tablet. Globalt anerkendt m\u00e6rke brugt siden 1960'erne; det samme molekyle som Synthroid og Levoxyl.\n<a href=\"https:\/\/medsbase.com\/da\/thyronorm\/\"><strong>Thyronorm<\/strong><\/a> \u2014 Abbott India, fuld titreringsomr\u00e5de p\u00e5 25\/50\/100\/125\/150 mcg. Den mest udbredt anvendte levothyroxin i Indien.\n<a href=\"https:\/\/medsbase.com\/da\/thyrox\/\"><strong>Thyrox<\/strong><\/a> \u2014 Macleods Pharmaceuticals, 25\/100\/125\/200 mcg. Inkluderer den h\u00f8jere 200 mcg styrke, som er nyttig til TSH-suppression efter thyreoidektomi.\n<a href=\"https:\/\/medsbase.com\/da\/l-thyroid\/\"><strong>L-Thyroid<\/strong><\/a> &mdash; budget option, full 25 to 150 mcg titration range.\n\n\nLiothyronine (T3) &mdash; second-line\n<a href=\"https:\/\/medsbase.com\/da\/liothyronine\/\"><strong>Liothyronin 25 mcg<\/strong><\/a> is synthetic T3 &mdash; about four times more potent than levothyroxine, with a much shorter half-life (~24 hours). Liothyronine bypasses the T4-to-T3 conversion step entirely. Its place in therapy is narrow:\n\nA <strong>lille ekstra dosis sammen med levothyroxin<\/strong> in selected patients with persistent hypothyroid symptoms despite a normal TSH on T4 monotherapy &mdash; usually a specialist endocrinology decision after other causes are excluded.\nShort-term <strong>forberedelse til thyroidekr\u00e6ft-scanninger<\/strong> (muligg\u00f8r hurtigere TSH-stigning efter oph\u00f8r).\n<strong>Myx\u00f8demkoma<\/strong> in hospital, given intravenously alongside T4.\nOff-label augmentation in <strong>behandlingsresistent depression<\/strong>.\n\nLiothyronine is <strong>ikke<\/strong> a wholesale replacement for levothyroxine and is not a weight-loss drug &mdash; misuse in euthyroid people causes atrial fibrillation, bone loss and muscle wasting. The Cochrane systematic review found no consistent benefit of T4+T3 over T4 monotherapy for routine quality-of-life improvement.\n\nThyroid nutritional support &mdash; not a treatment substitute\n<a href=\"https:\/\/medsbase.com\/da\/thyropace\/\"><strong>Thyropace<\/strong><\/a> er et L-Tyrosin + Jod kapseltilskud. Det er inkluderet i denne kategori, fordi det st\u00f8tter skjoldbruskkirtlens funktion ern\u00e6ringsm\u00e6ssigt, men det er ikke <strong>ikke<\/strong> a substitute for levothyroxine in diagnosed hypothyroidism. Thyropace can be appropriate for confirmed mild iodine deficiency or as adjunct nutritional support during pregnancy. It should be avoided in autoimmune Hashimoto&rsquo;s thyroiditis, Graves&rsquo; disease, and before radioiodine scanning &mdash; excess iodine flares autoimmunity and complicates radio-tracer imaging.\n\nCritical absorption rules for any T4 or T3 product\nLevothyroxine and liothyronine absorption are dramatically reduced by food, coffee, soy and several common medications. The rules below are essential, not optional:\n\nTake on an <strong>tom mave<\/strong>, first thing in the morning, with plain water.\nWait <strong>30\u201360 minutter<\/strong> before any food, coffee or other tablet.\nSeparate from <strong>calcium, jern, magnesium, zink, aluminium<\/strong> supplements \/ antacids by at least 4 hours.\nSeparate from <strong>protonpumpeh\u00e6mmere<\/strong> (omeprazole, esomeprazole, pantoprazole) &mdash; gastric acid is needed for full absorption.\nSeparate from <strong>cholestyramin, sevelamer eller orlistat<\/strong> med mindst 4 timers mellemrum.\n<strong>Graviditet:<\/strong> behovet for levothyroxin stiger 25\u201350% midt i graviditeten \u2014 kontroller TSH hver 4. uge i f\u00f8rste halvdel af graviditeten.\n<strong>\u00c6ldre \/ hjertepatienter:<\/strong> start low (25&ndash;50 mcg) and titrate slowly to avoid triggering ischaemia or atrial fibrillation.\n\n\nEvery product in this category is dispatched from a <strong>WHO-GMP certificeret producent<\/strong>, FDA-godkendt generisk produkt hvor relevant, med diskret emballage og verdensomsp\u00e6ndende forsendelse. Hver produktside indeholder en TSH-titreringstabel, fuld liste over l\u00e6gemiddelinteraktioner, bivirkningsprofil ved over- vs. underbehandling, og et h\u00e5ndplukket panel med alternative produkter.","link":"https:\/\/medsbase.com\/da\/underactive-thyroid-treatment\/","name":"Behandling af underaktiv skjoldbruskkirtel","slug":"underactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product?product_cat=3790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}